BLIV vs TACT

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a strong Current Ratio of 24.19 and moderate gross margin of 48.98%, the company is deeply unprofitable with an operating margin of -1507.43% and ROE of -109.04%. Revenue has collapsed by 54.20% year-over-year, and valuation multiples like Price/Sales of 22.48 are extremely high for a shrinking, unprofitable business. The stock has underperformed over the long term despite a short-term 6M gain, and peer comparisons show similar distressed profiles with no clear catalysts.

TACT exhibits severe fundamental weakness as evidenced by a Piotroski F-Score of 2/9, indicating a deteriorating financial position. While the company maintains a strong liquidity profile with a current ratio of 2.97 and very low debt (D/E 0.11), it is unable to translate healthy gross margins (48.59%) into net profitability. The long-term price trajectory is aggressively bearish, with a 5-year decline of 72.7%, and insider sentiment remains negative. Despite a low Price-to-Sales ratio of 0.65, the lack of earnings and poor operational health suggest a value trap.